Discovery and Preclinical Characterization of 1-Methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1 H -pyrazolo-[3,4- b ]pyrazine (PF470): A Highly Potent, Selective, and Efficacious Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator

Citations Over TimeTop 10% of 2014 papers

Abstract

A novel series of pyrazolopyrazines is herein disclosed as mGluR5 negative allosteric modulators (NAMs). Starting from a high-throughput screen (HTS) hit (1), a systematic structure-activity relationship (SAR) study was conducted with a specific focus on balancing pharmacological potency with physicochemical and pharmacokinetic (PK) properties. This effort led to the discovery of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo[3,4-b]pyrazine (PF470, 14) as a highly potent, selective, and orally bioavailable mGluR5 NAM. Compound 14 demonstrated robust efficacy in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-rendered Parkinsonian nonhuman primate model of l-DOPA-induced dyskinesia (PD-LID). However, the progression of 14 to the clinic was terminated because of a potentially mechanism-mediated finding consistent with a delayed-type immune-mediated type IV hypersensitivity in a 90-day NHP regulatory toxicology study.

Related Papers

• → Synthesis and thermal properties of the inorganic–organic transition metal halogenides CuCl–pyrazine and Cu2Cl2–pyrazine(2001)57 cited
• → Dimetalation of Pyrazines. A One-Pot Synthesis of Multisubstituted Pyrazine C-Nucleosides(2001)24 cited
• → Spectroscopic studies of the complexes trans-[PtX2(CH2CH2)(pyrazine)] and trans-[Pt2X4(CH2CH2)2-(pyrazine)](1983)7 cited
• → 222. Pyrazine derivatives. Part IV. Pyrazine N-oxides and their conversion into chloropyrazines(1947)8 cited
• Recognition of the Formation Mechanism & Flavor Characteristics of Pyrazine Compounds in Jiugui Liquor(2005)